> Antigenics' brain cancer vaccine Oncophage has won orphan drug status from the FDA. The news sent its share price up 41 percent. Report
> Alnylam Pharmaceuticals and Isis Pharmaceuticals have forged a new collaboration to advance single-strand RNAi technology. Story
> Stallergenes S.A. says it has reaped positive data from its phase IIb/III clinical trial on a sublingual house dust mite desensitization tablet. Release
> LAB Research has secured a $7.5 million loan from Investissement Québec. Release
> The FDA says it has ruled on a measure that requires manufacturers of over-the-counter pain relievers and fever reducers to include tougher safety warnings on their labels. Report
> The government's top medical advisers are now putting their two cents into the conflict of interest debate. The Institute of Medicine says that collaborations between medical professionals and drugmakers can benefit society, but financial ties are getting in the way. Report
> Earnings season marches on with word from Wyeth (soon to be swallowed by Pfizer, which reported last week) and Sanofi-Aventis, plus pharmacy benefits manager Medco Health Solutions. Report
> CEO Chris Viehbacher (photo) sounds a note of caution: If the company focuses on developing a shot against swine flu, it won't be able to churn out its usual season flu vaccines, too. Report
> Forget runs on shaky banks. Now, the big run is on pharmacies as a nervous public clamors for anti-flu meds. Report
And Finally... South Korean scientists say they have bred beagles that glow red in the dark. The scientists inserted fluorescent genes into eggs, a process that will help advance a new approach to treating disease. Report